News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Professor Louise Kenny has been appointed as chair of one of the four Research Excellence Framework (REF) 2029 main panels.

AMLo Biosciences has developed a diagnostic test called AMBLor, which allows clinicians to ascertain whether early-stage melanomas are at low-risk of progression.

AI-Sight – the University of Liverpool AI diagnostic technology spin-out based at Sci-Tech Daresbury – has successfully concluded its seven-figure equity funding round from experienced h...

Chemistry Week is taking place 4 – 10 November 2024, and this year’s theme is “Chemistry is Shaping the Future”. The impact of chemistry is vast, from reducing our carbon footprint a...

Monument Therapeutics, a leader in precision neuroscience, has announced a significant £1 million equity investment from the Forster Foundation, a charitable organization.

£4.2m funding available to support UK SMEs with MedTech regulations

The Hartree National Centre for Digital Innovation (HNCDI) partners, STFC and IBM Research, in cooperation with Bionow and The European Laboratory Research & Innovation Group (ELRIG), are is...

BioCap 2024 saw a great turnout of 155 delegates, exhibitors, speakers and investors at the conference itself as part of a three-day programme comprising of the digital pitching competition ...

Cambridge, UK: BioTryp Therapeutics, an award-winning drug discovery spin-out from the University of Cambridge, has raised £300k in pre-seed funding to advance the development of its novel ...

After much deliberation, Bionow is once again delighted to announce the pitching competition finalists for this year’s BioCap conference.

F2G Ltd, a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening rare fungal infections with a high unmet medical nee...

With an initial investment of £28 million in resource and funding from LifeArc and Cancer Research UK, the consortium will bring together researchers, clinicians, scientists and industry to...

Our Valued Sponsors & Partners